Genmab is an international biotechnology company specializing in the creation and development of differentiated human antibody therapeutics for the treatment of cancer.
Quote | Genmab A/S S/Adr (OTCMKTS:GMXAY)
Last: | $ |
---|---|
Change Percent: | 0.88% |
Open: | $18.2401 |
Close: | $18.35 |
High: | $18.35 |
Low: | $18.23 |
Volume: | 13,143 |
Last Trade Date Time: | 07/18/2019 08:54:42 am |
News | Genmab A/S S/Adr (OTCMKTS:GMXAY)
BioNTech ( NASDAQ: BNTX ) and Genmab ( GMAB ) are expanding their collaboration to develop and commercialize novel immunotherapies to treat patients with cancer. Under the new agreement, the companies will jointly develop and commercialize, subject to regulato...
Genmab A/S ( OTCPK:GMXAY -2.1% ) announces that licensee Johnson & Johnson ( JNJ -1.7% ) unit Janssen Biotech has launched its U.S. marketing application seeking approval to use Darzalex (daratumumab), combined with Celgene's Revlimid (lenalidomide) and dexamethasone, in treatment-...
Message Board Posts | Genmab A/S S/Adr (OTCMKTS:GMXAY)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Genmab A/S S/Adr Company Name:
GMXAY Stock Symbol:
OTCMKTS Market:
Genmab A/S webcast presentation now available for on-demand viewing: dbVIC - Deutsche Bank ADR Virtual Investor Conference Canada NewsWire COPENHAGEN, Denmark, March 26, 2018 Company invites individual and institutional investors, as well as advisors, to log-on to view...
NEW YORK , March 21, 2018 /PRNewswire/ -- Deutsche Bank today announced the addition of presenters for its Depositary Receipts Virtual Investor Conference ("dbVIC") on March 22 nd , featuring live webcast presentations from international companies with American Depositary Receipt (...
Genmab A/S to present at the dbVIC - Deutsche Bank ADR Virtual Investor Conference on March 22, 2018 Canada NewsWire COPENHAGEN, Denmark, March 21, 2018 Company invites individual and institutional investors, as well as advisors, to attend interactive, real-time virtual ev...